Your search returned 48 results.

Results
	41.	Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearance. [electronic resource] by Bulitta, Jürgen B Okusanya, Olanrewaju O Forrest, Alan Bhavnani, Sujata M Clark, Kay Still, J Gordon Fernandes, Prabhavathi Ambrose, Paul G Producer: 20130610 In: Antimicrobial agents and chemotherapy vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	42.	Evaluation of the pharmacokinetics-pharmacodynamics of fusidic acid against Staphylococcus aureus and Streptococcus pyogenes using in vitro infection models: implications for dose selection. [electronic resource] by Okusanya, Olanrewaju O Tsuji, Brian T Bülitta, Jurgen B Forrest, Alan Bulik, Catharine C Bhavnani, Sujata M Fernandes, Prabhavathi Ambrose, Paul G Producer: 20110802 In: Diagnostic microbiology and infectious disease vol. 70 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	43.	A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections. [electronic resource] by Craft, J Carl Moriarty, Susan R Clark, Kay Scott, Drusilla Degenhardt, Thorsten P Still, J Gordon Corey, G Ralph Das, Anita Fernandes, Prabhavathi Producer: 20110727 In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 52 Suppl 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	44.	SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia. [electronic resource] by File, Thomas M Rewerska, Barbara Vucinic-Mihailovic, Violeta Gonong, Joven Roque V Das, Anita F Keedy, Kara Taylor, David Sheets, Amanda Fernandes, Prabhavathi Oldach, David Jamieson, Brian D Producer: 20171222 In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	45.	A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. [electronic resource] by George, Mark S Molnar, Christine E Grenesko, Emily L Anderson, Berry Mu, Qiwen Johnson, Kevin Nahas, Ziad Knable, Michael Fernandes, Prabhavathi Juncos, Jorge Huang, Xuemei Nichols, David E Mailman, Richard B Producer: 20070830 In: Schizophrenia research vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	46.	A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia. [electronic resource] by Mu, Qiwen Johnson, Kevin Morgan, Paul S Grenesko, Emily L Molnar, Christine E Anderson, Berry Nahas, Ziad Kozel, F Andrew Kose, Samet Knable, Michael Fernandes, Prabhavathi Nichols, David E Mailman, Richard B George, Mark S Producer: 20071011 In: Schizophrenia research vol. 94 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	47.	Solithromycin Pharmacokinetics in Plasma and Dried Blood Spots and Safety in Adolescents. [electronic resource] by Gonzalez, Daniel Palazzi, Debra L Bhattacharya-Mithal, Leena Al-Uzri, Amira James, Laura P Bradley, John Neu, Natalie Jasion, Theresa Hornik, Christoph P Smith, P Brian Benjamin, Daniel K Keedy, Kara Fernandes, Prabhavathi Cohen-Wolkowiez, Michael Producer: 20161213 In: Antimicrobial agents and chemotherapy vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	48.	Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL). [electronic resource] by Barrera, Carlos M Mykietiuk, Analia Metev, Hristo Nitu, Mimi Floarea Karimjee, Najumuddin Doreski, Pablo Alexis Mitha, Ismail Tanaseanu, Cristina Mihaela Molina, Joseph McDermott Antonovsky, Yuri Van Rensburg, Dirkie Johanna Rowe, Brian H Flores-Figueroa, Jose Rewerska, Barbara Clark, Kay Keedy, Kara Sheets, Amanda Scott, Drusilla Horwith, Gary Das, Anita F Jamieson, Brian Fernandes, Prabhavathi Oldach, David Producer: 20160823 In: The Lancet. Infectious diseases vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)